Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR | P41180 | 18/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 8/20 | 0.66 |
| ▸ | ADRB2 | P07550 | 8/20 | 0.66 |
| ▸ | SLC6A2 | P23975 | 7/20 | 0.66 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.66 |
| ▸ | SLC6A3 | Q01959 | 7/20 | 0.66 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.66 |
| ▸ | ADRB3 | P13945 | 4/20 | 0.66 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6861960 | 1.00 | CASR (0.66) | CASRCYP2D6ADRB2SLC6A2SLC6A4 | |
| Hydrochloric Acid SCHEMBL6857936 | 0.99 | CASR (0.65) | CASRCYP2D6ADRB2SLC6A2SLC6A4 | |
| Hydrochloric Acid SCHEMBL6857942 | 0.99 | CASR (0.65) | CASRCYP2D6ADRB2SLC6A2SLC6A4 | |
| SCHEMBL6862114 | 0.89 | CASR (0.61) | CASRCYP2D6ADRB2SLC6A2SLC6A4 | |
| SCHEMBL6862107 | 0.89 | CASR (0.61) | CASRCYP2D6ADRB2SLC6A2SLC6A4 | |
| SCHEMBL6862538 | 0.88 | CASR (0.64) | CASRCYP2D6ADRB2SLC6A2SLC6A4 | |
| Hydrochloric Acid SCHEMBL6863037 | 0.88 | CASR (0.60) | CASRCYP2D6ADRB2SLC6A2SLC6A4 | |
| Hydrochloric Acid SCHEMBL7802320 | 0.88 | CASR (0.60) | CASRCYP2D6ADRB2SLC6A2SLC6A4 | |
| SCHEMBL6862116 | 0.87 | CASR (0.65) | CASRCYP2D6ADRB2SLC6A2SLC6A4 | |
| SCHEMBL6862123 | 0.87 | CASR (0.65) | CASRCYP2D6ADRB2SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0973730-B1 | CALCILYTIC COMPOUNDS | SMITHKLINE BEECHAM CORP (US) | 2004-06-16 | — | — | EP | claimed |
| US-6294531-B1 | AMINOALKANOLS AS BLOOD COAGULANTS | SMITHKLINE BEECHAM CORPORATION | 2001-09-25 | — | — | US | claimed |
| CN-1259120-A | Calcilytic compounds | SMITHKLINE BEECHAM CORP (US) | 2000-07-05 | — | — | CN | claimed |
| EP-0973730-A1 | CALCILYTIC COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-01-26 | — | — | EP | claimed |
| WO-1998045255-A1 | CALCILYTIC COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-10-15 | — | — | WO | claimed |
| EP-0973730-B1 | CALCILYTIC COMPOUNDS | SMITHKLINE BEECHAM CORP (US) | 2004-06-16 | — | — | EP | disclosed |
| US-6294531-B1 | AMINOALKANOLS AS BLOOD COAGULANTS | SMITHKLINE BEECHAM CORPORATION | 2001-09-25 | — | — | US | disclosed |
| CN-1290174-A | Compositions and methods for systemic delivery of oral vaccines and therapeutics | UNIV JEFFERSON (US) | 2001-04-04 | — | — | CN | disclosed |
| CN-1259120-A | Calcilytic compounds | SMITHKLINE BEECHAM CORP (US) | 2000-07-05 | — | — | CN | disclosed |